The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.
|Articles|July 21, 2003
New flu vaccine caters to the "needle-phobic"
Just in time for the 2003/2004 flu season, clinicians will be able to offer their "needle phobic" patients the first cold-adaptive, live-attenuated influenza vaccine (CAIV) that is administered as a nasal spray. The FDA recently approved influenza virus vaccine live, intranasal (FluMist, MedImmune Vaccines/Wyeth Vaccines) for active immunization for the prevention of disease caused by influenza A and B viruses in healthy children and adolescents, 5 to 17 years old, and healthy adults, 18 to 49 years old. The vaccine will be available in pharmacies beginning in the late summer to early fall.
Advertisement
Advertisement
Related to this article
The Milken Institute released survey results alongside new data regarding the need for pharmacists in extending effective GLP-1 care.
Through the ACCESS program, Mark Ey, RPh, notes that pharmacies can now start billing for a variety of services they’ve already been providing.
The medication significantly increased risk of pregnancy loss when compared with macrolide antibiotics, amoxicillin, and topical clindamycin for acne.
In part 3, Rebold explores improving the ART formulary protocol through introducing pharmacist-led transition-of-care services.
Our hosts explore why ketone monitoring matters, what pharmacists should know about Libre Duo, and how patient education can support proactive care management.
Mark Ey, RPh, details the patient-focused factors of the ACCESS to Pharmacy Care Program and the ways in which valued care translates to reimbursement.
A new option for adults who have experienced stroke will now be available to further reduce future risk.
Advertisement
Advertisement
Trending on Drug Topics
1
The Pharmacy Model Creating New Billing Pathways, Improved Recognition
2
Doxycycline Use Associated with Higher Risk of Pregnancy Loss
3
Wicked Good Cardiometabolic Chat: Ketone Monitoring in Pharmacy Practice
4
Pharmacist-Led Transitions of Care Could Be Crucial in HIV Treatment
5